24 August 2020
Release date 20 August 2020
MTPConnect Chair Sue MacLeman has been appointed to the group of medical and industry experts which will be led by the Secretary of the Department of Health, Professor Brendan Murphy, and will provide advice to the Australian Government on the purchasing and manufacturing of COVID-19 vaccines and treatments.
To support the Australian Government to make decisions about purchasing and manufacture of COVID-19 vaccines and treatments the COVID-19 Vaccines and Treatments for Australia – Science and Industry Technical Advisory Group will provide advice on:
Sue MacLeman explained that collaboration between government, science, health and industry on the nation’s COVID-19 response has never been more important.
“I’m honoured to be appointed to this Advisory Group as we come together to further respond to the COVID-19 pandemic and protect the health of Australians,” said Ms MacLeman.
“The MTP sector is on the front line for research, diagnosis, management, prevention and treatment of infectious diseases and has a critical role to play in driving Australia’s COVID-19 response.
“There is an enormous opportunity for the Australian medical research community and our advanced manufacturing sector to be involved in the delivery of vaccines and treatments.”
Read more about Australia’s COVID-19 Vaccine and Treatments Strategy.